Search Results 831-840 of 24294 for In situ

  1. Curriculum - Multidisciplinary Breast Pathology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    ... in situ hybridization. The majority and remainder of the fellow's experience will be in Surgical Pathology devoted to intensive training in the diagnostic ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    ... in the United States, with campuses in Arizona, Florida and Minnesota. Staff ... situ, Squamous cell carcinoma of the skin, Ductal carcinoma in situ ...

  3. Paget's disease of the breast - Symptoms & causes - Mayo Clinic

    Having certain breast conditions raises your risk of breast cancer. These conditions include lobular carcinoma in situ, also called LCIS, and atypical ...

  4. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Adequately treated cervical carcinoma in situ without current evidence of disease. Currently active clinically significant cardiovascular disease such as ...

  5. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

    Subject has a history of active malignancies other than SCLC within the past 2 years prior to study entry, with the exception of in situ cancer which was ...

  6. Hepatobiliary and Pancreas Surgery in Rochester - Doctors - Mayo Clinic

    ... in situ cold perfusion, Robotic splenectomy, Cholangiocarcinoma, Pancreatic cancer, Ampullary cancer, Hilar cholangiocarcinoma, Immune thrombocytopenia ...

  7. Safety And Efficacy Study Of Filgotinib, GS-9876 And Tirabrutinib In Adults With Active Sjogren's Syndrome - Mayo Clinic

    ... in situ, with no evidence of recurrence). Positive serology for human immunodeficiency virus (HIV) 1 or 2 at Screening. Hepatitis B virus (HBV) surface ...

  8. A Study to Evaluate Lung Function in Subjects with Idiopathic Pulmonary Fibrosis (IPF) After Taking BI 1015550 for 12 Weeks - Mayo Clinic

    ... in situ carcinoma of uterine cervix. Evidence of active infection (chronic or acute) based on clinical exam or laboratory findings at Visit 1 or at Visit 2 ...

  9. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    Adequately treated carcinoma in situ without current evidence of disease - Any systemic anti-lymphoma and/or investigational therapy prior to the start of ...

  10. Medical Research & Education - Mayo Clinic News Network

    Aging and Immune Decline: Destiny or Dynamic? Mayo Clinic Staff. October 20, 2020. Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ vaccine ...